March 11, 2020 / 1:05 PM / 25 days ago

BRIEF-Ovid Therapeutics Reports Q4 Loss Per Share $0.35

March 11 (Reuters) - Ovid Therapeutics Inc:

* OVID THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS, PROVIDES CORPORATE UPDATE FOR 2020

* Q4 LOSS PER SHARE $0.35

* Q4 EARNINGS PER SHARE ESTIMATE $-0.41 — REFINITIV IBES DATA

* OVID THERAPEUTICS - AS OF DECEMBER 31, 2019, CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TOTALED $76.7 MILLION

* OVID THERAPEUTICS - EXPECTS RESULTS FROM PHASE 2 ROCKET TRIAL & SKYROCKET TRIAL IN FRAGILE X SYNDROME EARLY IN SECOND QUARTER OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below